EMCURE PHARMACEUTICALS L Share Price
NSE: EMCURE|BSE: 544210|Pharmaceuticals₹1,350.00
-₹22.70 (-1.65%) As on 08 Sep, 2025 | 15:29 ISTEMCURE PHARMACEUTICALS L Stock Performance
Market cap  ₹26,014 Crs | Open ₹1,378.00 | Prev. Close ₹1,372.70 |
Circuit range ₹1,509.90 - ₹1,235.50 | Day range ₹1,347.30 - ₹1,399.00 | Year range ₹889.00 - ₹1,580.00 |
Volume 57,836 | Avg. traded ₹1,366.07 | Revenue (12m) ₹8,181 Crs |
About EMCURE PHARMACEUTICALS L
Emcure Pharmaceuticals Limited is an India-based pharmaceutical company, which is engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several major therapeutic areas. It offers a range of products and services under formulations, biologics and APIs. It operates across a wide scope of areas, including gynecological, cardiology, antivirals, vitamins, pain/analgesics, anti-neoplastic, diabetes, anti-infective, respiratory, CNS and nephrology. Its brands include OROFER (Gynecological), BEVON (Vitamins), ZOSTUM (Anti- infectives), Ferium (Gynecological), EXHEP (Cardiovascular), Maxtra (Respiratory) and Pause (Blood-Related). Its API products include S-Amlodipine, Dydrogesterone, Ferric Carboxymaltose, Ferrous Ascorbate and Eribulin. Its biologics business offers various products, including Elaxim (cardiology), Vintor (nephrology), Xgrast (anti-neoplastic) and Pegex (anti- neoplastic). It has developed two platforms: Mammalian and Microbial.
As of last trading day, EMCURE PHARMACEUTICALS L opened at ₹1,378.00 and last traded at ₹1,350.00, showing a fall of 22.70 points (1.65%) compared to the previous close of ₹1,372.70. During the session, the stock touched a high of ₹1,399.00 and a low of ₹1,347.30. The company's market capitalization now stands at ₹26,014 Crs, with a P/E ratio of 34.9 and a dividend yield of 0.28%.
09 September 2025 – EMCURE PHARMACEUTICALS L Share Price Update
As of last trading day, EMCURE PHARMACEUTICALS L opened at ₹1,378.00 and last traded at ₹1,350.00, showing a fall of 22.70 points (1.65%) compared to the previous close of ₹1,372.70. During the session, the stock touched a high of ₹1,399.00 and a low of ₹1,347.30. The company's market capitalization now stands at ₹26,014 Crs, with a P/E ratio of 34.9 and a dividend yield of 0.28%.EMCURE PHARMACEUTICALS L Share Price Chart
₹1,350.00-₹22.70 (-1.65%)
Please wait...
EMCURE PHARMACEUTICALS L Key Indicators
P/E ratio 34.89 | P/B ratio 4.57 | ROE 12.79% |
ROCE 14.36% | Dividend yield 0.28% | Debt/Equity ratio 0.49 |
EPS 16.95 |
Investment Checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst Ratings:
75%
Hold
25%
Sell
0%
This analysis is based on the reviews of 4 experts in the last 7 days
EMCURE PHARMACEUTICALS L Financial Ratios
Operating profit margin17.47% | Net profit margin7.24% |
ROE12.79% | ROA8.05% |
ROCE14.36% |
Quick ratio0.83 | Current ratio1.17 |
Interest coverage4.79 | Asset turnover1.19 |
Debt to Equity0.49 |
P/E ratio34.89 | P/B ratio4.57 |
EV / EBITDA27.65 | |
Dividend yield0.28% |
EMCURE PHARMACEUTICALS L Revenue Statement
All values are in ₹ Crores (Cr)
Year  | Revenue  | Operating Profit | Net Profit |
|---|---|---|---|
Mar-25 | ₹7,963.26 | ₹971.35 | ₹707.47 |
Mar-24 | ₹6,715.24 | ₹727.23 | ₹527.58 |
Mar-23 | ₹6,031.72 | ₹747.22 | ₹561.85 |
Mar-22 | ₹5,918.86 | ₹972.55 | ₹702.56 |
EMCURE PHARMACEUTICALS L Cash Flow
All values are in ₹ Crores (Cr)
Year | Operating | Investing | Financing |
|---|---|---|---|
Mar-25 | ₹-94 | ₹-813.96 | |
Mar-24 | ₹-712.51 | ₹-164.21 | |
Mar-23 | ₹-467.69 | ₹-145.40 | |
Mar-22 | ₹-788.79 | ₹-151.85 |
EMCURE PHARMACEUTICALS L Balance Sheet
All values are in ₹ Crores (Cr)
Period | Total Asset | Total Liability |
|---|---|---|
Mar-25 | ₹8,232.72 | ₹8,232.72 |
Mar-24 | ₹7,806.16 | ₹7,806.16 |
Mar-23 | ₹6,672.53 | ₹6,672.53 |
Mar-22 | ₹6,063.47 | ₹6,063.47 |
EMCURE PHARMACEUTICALS L Share Price History
| Day | Open | Close | Change % |
|---|---|---|---|
22-Aug-25 | ₹1,470.00 | ₹1,493.10 | |
21-Aug-25 | ₹1,515.00 | ₹1,470.00 | -2.29% |
20-Aug-25 | ₹1,471.00 | ₹1,504.50 | |
19-Aug-25 | ₹1,449.00 | ₹1,470.20 | |
18-Aug-25 | ₹1,461.50 | ₹1,453.50 | -0.09% |
14-Aug-25 | ₹1,470.90 | ₹1,454.80 | |
13-Aug-25 | ₹1,408.50 | ₹1,453.80 | |
12-Aug-25 | ₹1,386.00 | ₹1,408.50 |
EMCURE PHARMACEUTICALS L Corporate Actions
Dividend • ₹3/share
Ex date 14 Aug 2025
Popular Stocks
Stock Name | Price | Change % |
|---|---|---|
| Bajaj Housing Share Price | ₹112.22 | +₹0.01 (0.01%) |
| HDFC Bank Share Price | ₹966.00 | +₹2.60 (0.27%) |
| Indian Railway Finance Corp Share Price | ₹124.57 | +₹1.11 (0.90%) |
| JIO FIN SERVICES LTD Share Price | ₹311.10 | +₹1.70 (0.55%) |
| LIC Share Price | ₹876.55 | -₹0.80 (-0.09%) |
| NTPC Share Price | ₹326.70 | -₹2.00 (-0.61%) |
| Reliance Share Price | ₹1,378.50 | +₹3.50 (0.25%) |
| Tata Motors Share Price | ₹719.50 | +₹27.80 (4.02%) |
| Tata Power Share Price | ₹383.25 | -₹2.55 (-0.66%) |
| Tata Steel Share Price | ₹168.82 | +₹1.14 (0.68%) |
EMCURE PHARMACEUTICALS L News
Upstox
Emcure Pharmaceuticals Q1 net profit rises 41% at ₹215 crore, revenue up 16%
Upstox
Emcure Pharma, Sanofi ink pact for oral anti-diabetic product distribution in India
VCCircle
Bain Capital-backed Emcure takes full control of Zuventus Healthcare
Moneycontrol
Emcure Pharmac Consolidated March 2025 Net Sales at Rs 2,116.25 crore
Upstox
SHARKS impress the Street in Q4! Namita Thapar's Emcure Pharma shares hit 10%, Ghazal Alagh's Honasa Consumer zooms 20%
Moneycontrol
Emcure Pharma Standalone March 2025 Net Sales at Rs 1,278.19 crore
Upstox
SENSEX surges over 950 points; ITC, Emcure, Honasa, Waaree Energies among buzzing stocks
Livemint
Emcure Pharmaceuticals shares surge 20% in two sessions after robust Q4
Moneycontrol
Top gainers and losers today: Stocks that moved the most on May 22
CNBC Television
Emcure Pharma Q4 Results: Stock rises 8% after net profit grows 64% from
EMCURE PHARMACEUTICALS L Share Price FAQs
What is the share price of EMCURE PHARMACEUTICALS L today?
EMCURE PHARMACEUTICALS L share price is ₹ 1,350.00 as on Sep, 2025 | 15:29 IST.
What are the high & low stock price of EMCURE PHARMACEUTICALS L today?
EMCURE PHARMACEUTICALS L stock price hit a high of ₹ 1,399.00 and low of ₹ 1,347.30 as on Sep, 2025 | 15:29 IST.
What is the market cap of EMCURE PHARMACEUTICALS L?
The market cap of EMCURE PHARMACEUTICALS L is ₹ 26,013.81 Crores as on Sep, 2025 | 15:29 IST.
What are the the 52-week high and low share prices of EMCURE PHARMACEUTICALS L stock on the NSE?
52-week high stock Price of EMCURE PHARMACEUTICALS L is ₹ 1,580.00 and Low Price is ₹ 889.00 as on Sep, 2025 | 15:29 IST.
What are the stock symbols of EMCURE PHARMACEUTICALS L?
The stock symbol of EMCURE PHARMACEUTICALS L is NSE: EMCURE on the NSE, BSE: 544210 on the BSE, and the ISIN is INE168P01015.
Can I buy EMCURE PHARMACEUTICALS L shares on Holidays?
No, shares of EMCURE PHARMACEUTICALS L or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell EMCURE PHARMACEUTICALS L shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
How to buy EMCURE PHARMACEUTICALS L shares?
To buy EMCURE PHARMACEUTICALS L shares,open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order
What is the PE and PB ratio of EMCURE PHARMACEUTICALS L?
The PE and PB ratio of EMCURE PHARMACEUTICALS L is 34.89 and 4.57 respectively, as on Sep, 2025 | 15:29 IST.
What are the returns on EMCURE PHARMACEUTICALS L shares?
The historical returns for EMCURE PHARMACEUTICALS L shares are -2.32 for 1 year, 1 for 3 year and 1 for 5 year.